Bakgrunn og aktiviteter
Stein Kaasa is Professor of Palliative Medicine at the Institute of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim (NTNU). His responsibilities include the development of the core curriculum in palliative medicine and the development of the Nordic specialist postgraduate training curriculum in palliative medicine. Professor Kaasa’s main research interests are: basic research in assessment and classification of symptoms and subjective health; experimental and descriptive clinical studies in palliative medicine and cancer research; pain treatment including translational research on opioids and on cachexia.
Professor Kaasa has published more than 400 articles and book chapters. He has authored the Nordic Textbook of Palliative Care and is co-author of the Oxford Textbook of Palliative Medicine. Professor Kaasa advises many international journals – either as an advisory board member or as a reviewer (Journal of Pain and Symptom Management, Palliative Medicine, Journal of Palliative Medicine, Oncology, Journal of Clinical Oncology, Pain, Lancet Oncology).
Vitenskapelig, faglig og kunstnerisk arbeid
Et utvalg av nyere tidsskriftspublikasjoner, kunstneriske produksjoner, bok, inklusiv bokdeler og rapport-del. Se alle publikasjoner i databasen
- (2018) Multimodal behandling av kakeksi hos kreftpasienter. Bestpractice Onkologi/Hematologi. vol. 36.
- (2018) Cancer patients' knowledge about their disease and treatment before, during and after treatment: a prospective, longitudinal study. BMC Cancer. vol. 18:381.
- (2018) Predictors and trajectory of performance status in patients with advanced cancer: A secondary data analysis of the international European Palliative Care Cancer Symptom study. Palliative Medicine. vol. 33(2).
- (2018) Patients with advanced cancer and depression report a significantly higher symptom burden than non-depressed patients. Palliative & Supportive Care.
- (2018) The Palliative Radiotherapy and Inflammation Study (PRAIS) - Protocol for a longitudinal observational multicenter study on patients with cancer induced bone pain. BMC Palliative Care. vol. 17 (110).
- (2018) Which factors can aid clinicians to identify a risk of pain during the following month in patients with bone metastases? A longitudinal analyses. Supportive Care in Cancer.
- (2018) Sleep quality with WHO Step III opioid use for cancer pain. BMJ Supportive & Palliative Care.
- (2018) Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer: study protocol for a double-blind, randomized, placebo-controlled, clinical multicenter trial. Trials. vol. 19:707.
- (2018) Integration of oncology and palliative care: a Lancet Oncology Commission. The Lancet Oncology. vol. 19 (11).
- (2018) Usability testing of EirV3-a computer-based tool for patient-reported outcome measures in cancer. Supportive Care in Cancer.
- (2018) Usability testing of EirV3 - a computer-based tool for patient reported outcome measures in cancer. Annals of Oncology.
- (2018) Development and course of chronic pain over 4 years in the general population: The HUNT pain study. European Journal of Pain. vol. 22 (9).
- (2018) Preferred Place of Death and its Associated Factors among Patients with Advanced cancer in Norway. Palliative Medicine. vol. 32 (1_suppl).
- (2018) Pain Intensity Factors Changing Breakthrough Pain Prevalence in Patients with Advanced Cancer: A Secondary Analysis of a Cross-Sectional Observational International Study. Pain and Therapy. vol. 7 (2).
- (2018) The EORTC CAT Core?The computer adaptive version of the EORTC QLQ-C30 questionnaire. European Journal of Cancer. vol. 100.
- (2018) Resilience for family carers of advanced cancer patients-how can health care providers contribute? A qualitative interview study with carers. Palliative Medicine. vol. 32 (8).
- (2018) Cancer cachexia: Rationale for the MENAC (Multimodal - Exercise, Nutrition and Anti-inflammatory medication for Cachexia) trial. BMJ Supportive & Palliative Care. vol. 8.
- (2018) Dose to penile bulb is not associated with erectile dysfunction 18 months post radiotherapy: A secondary analysis of a randomized trial. Clinical and Translational Radiation Oncology. vol. 13.
- (2018) Radiotherapy for prostate cancer - Does daily image guidance with tighter margins improve patient reported outcomes compared to weekly orthogonal verified irradiation? Results from a randomized controlled trial. Radiotherapy and Oncology. vol. 126 (2).
- (2018) Ten-year survival after High-Dose-Rate Brachytherapy combined with External Beam Radiation Therapy in high-risk prostate cancer: A comparison with the Norwegian SPCG-7 cohort. Radiotherapy and Oncology.